Logo

Organon Signs Toxicogenomics Service Deal with Gene Logic

Jul 28, 2004

NEW YORK, July 28 (GenomeWeb News) - Gene Logic has signed a toxicogenomics services deal with Organon, the companies said today.

 

Under the eighteen-month deal, GeneLogic will provide ToxScreen and Mechanism of Toxicity reports to Organon in order to evaluate the safety and toxicity of its drug candidates. The  companies did not disclose the financial terms of the deal.

 

Organon has been a subscriber to Gene Logic's GeneExpress database since December 2000.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.